PARTHENON THERAPEUTICS Trademark
Trademark Overview
On Tuesday, June 13, 2023, a trademark application was filed for PARTHENON THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PARTHENON THERAPEUTICS trademark a serial number of 98039617. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 18, 2024. This trademark is owned by Parthenon Therapeutics Inc.. The PARTHENON THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
therapeutic preparations for the treatment of cancer
research and development; drug development and discovery services; scientific research and development; providing scientific research information; consulting services in the field of pharmaceutical research and development; all of the foregoing in the field of oncology
General Information
| Serial Number | 98039617 |
| Word Mark | PARTHENON THERAPEUTICS |
| Filing Date | Tuesday, June 13, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, June 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the word PARTHENON immediately above the word THERAPEUTICS, with a thin horizontal line to each side of the word THERAPEUTICS. To the left of this wording is a design of a structure consisting of three vertical columns, topped by a pointed roof. |
| Goods and Services | therapeutic preparations for the treatment of cancer |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | research and development; drug development and discovery services; scientific research and development; providing scientific research information; consulting services in the field of pharmaceutical research and development; all of the foregoing in the field of oncology |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 17, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 17, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Parthenon Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02135 |
Trademark Events
| Event Date | Event Description |
| Friday, June 16, 2023 | NEW APPLICATION ENTERED |
| Tuesday, July 18, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, July 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 4, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, March 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 18, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, June 18, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
